Potentiated L-type Ca2+ channels rectify.
Strong depolarization and dihydropyridine agonists potentiate inward currents through native L-type Ca2+ channels, but the effect on outward currents is less clear due to the small size of these currents. Here, we examined potentiation of wild-type alpha1C and two constructs bearing mutations in conserved glutamates in the pore regions of repeats II and IV (E2A/E4A-alpha1C) or repeat III (E3K-alpha1C). With 10 mM Ca2+ in the bath and 110 mM Cs+ in the pipette, these mutated channels, expressed in dysgenic myotubes, produced both inward and outward currents of substantial amplitude. For both the wild-type and mutated channels, we observed strong inward rectification of potentiation: strong depolarization had little effect on outward tail currents but caused the inward tail currents to be larger and to decay more slowly. Similarly, exposure to DHP agonist increased the amplitude of inward currents and decreased the amplitude of outward currents through both E2A/E4A-alpha1C and E3K-alpha1C. As in the absence of drug, strong depolarization in the presence of dihydropyridine agonist had little effect on outward tail currents but increased the amplitude and slowed the decay of inward tail currents. We tested whether cytoplasmic Mg2+ functions as the blocking particle responsible for the rectification of potentiated L-type Ca2+ channels. However, even after complete removal of cytoplasmic Mg2+, (-)BayK 8644 still potentiated inward current and partially blocked outward current via E2A/E4A-alpha1C. Although zero Mg2+ did not reveal potentiation of outward current by DHP agonist, it did have two striking effects, (a) a strong suppression of decay of both inward and outward currents via E2A/E4A-alpha1C and (b) a nearly complete elimination of depolarization-induced potentiation of inward tail currents. These results can be explained by postulating that potentiation exposes a binding site in the pore to which an intracellular blocking particle can bind and produce inward rectification of the potentiated channels.
Leuranguer
Valérie
V
Department of Anatomy and Neurobiology, Colorado State University, Fort Collins 80523, USA.
Dirksen
Robert T
RT
Beam
Kurt G
KG
D000818:Animals; D020746:Calcium Channels, L-Type / Q000502:physiology*; D018076:DNA, Complementary / Q000032:analysis; D004095:Dihydropyridines / Q000819:agonists; D004594:Electrophysiology; D005786:Gene Expression Regulation; D015640:Ion Channel Gating / Q000502:physiology*; D008274:Magnesium / Q000493:pharmacokinetics; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000166:cytology
D020746:Calcium Channels, L-Type; D018076:DNA, Complementary; D004095:Dihydropyridines; C038806:1,4-dihydropyridine; D008274:Magnesium